Anti-inflammatory effects of eplerenone on viral myocarditis

European Journal of Heart Failure

Volumn 11, Issue 4, 2009, Pages 349-353

  Xiao, Jie ^a,c   Shimada, Miho ^a   Liu, Wenling ^a,b   Hu, Dayi ^b   Matsumori, Akira ^a  

^a KYOTO UNIVERSITY   (Japan)

^b PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Eplerenone; Fibrosis; Heart failure; Inflammation; Mast cells; Myocarditis; Viruses

Indexed keywords

CHYMASE; EPLERENONE; GELATINASE B; PROCOLLAGEN C PROTEINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENCEPHALOMYOCARDITIS VIRUS; GENE EXPRESSION; HEART MUSCLE FIBROSIS; HISTOPATHOLOGY; INFLAMMATION; MALE; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL; VIRUS CONCENTRATION; VIRUS MYOCARDITIS;

ALDOSTERONE ANTAGONISTS; ANIMALS; CARDIOVIRUS INFECTIONS; DISEASE MODELS, ANIMAL; DNA, VIRAL; ENCEPHALOMYOCARDITIS VIRUS; MALE; MICE; MICE, INBRED DBA; MYOCARDITIS; MYOCARDIUM; POLYMERASE CHAIN REACTION; SPIRONOLACTONE; TREATMENT OUTCOME;

EID: 66249117976     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1093/eurjhf/hfp023     Document Type: Article

References (19)

1. Rajagopalan S, Duquaine D, King S, Pitt B, Patel P. Mineralocorticoid receptor antagonism in experimental atherosclerosis. Circulation 2002;105:2212-2216.
2. Virdis A, Neves MF, Amiri F, Viel E, Touyz RM, Schiffrin EL. Spironolactone improves angiotensin-induced vascular changes and oxidative stress. Hypertension 2002;40:504-510.
3. Keidar S, Kaplan M, Pavlotzky E, Coleman R, Hayek T, Hamoud S, Aviram M. Aldosterone administration to mice stimulates macrophage NADPH oxidase and increases atherosclerosis development: a possible role for angiotensin- converting enzyme and the receptors for angiotensin II and aldosterone. Circulation 2004;109:2213-2220.
4. Higuchi H, Hara M, Yamamoto K, Miyamoto T, Kinoshita M, Yamada T, Uchiyama K, Matsumori A. Mast cells play a critical role in the pathogenesis of viral myocarditis. Circulation 2008;118:363-372.
5. Matsumori A, Wang H, Abelmann WH, Crumpacker CS. Treatment of viral myocarditis with ribavirin in an animal preparation. Circulation 1985;71:834-839.
6. Kitaura-Inenaga K, Hara M, Higuchi K, Yamamoto K, Yamaki A, Ono K, Nakano A, Kinoshita M, Sasayama S, Matsumori A. Gene expression of cardiac mast cell chymase and tryptase in a murine model of heart failure caused by viral myocarditis. Circ J 2003;67:881-884.
7. Matsumori A, Higuchi H, Shimada M. French maritime pine bark extract inhibits viral replication and prevents development of viral myocarditis. J Card Fail 2007; 13:785-791.
8. Brown NJ. Aldosterone and vascular inflammation. Hypertension 2008;51: 161-167.
9. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 1994;74:1141-1148.
10. Hazan-Halevy I, Levy T, Wolak T, Lubarsky I, Levy R, Paran E. Stimulation of NADPH oxidase by angiotensin II in human neutrophils is mediated by ERK, p38 MAP-kinase and cytosolic phospholipase A2. J Hypertens 2005;23:1183-1190.
11. Zhang H, Schmeisser A, Garlichs CD, Plotze K, Damme U, Mugge A, Daniel WG. Angiotensin II-induced superoxide anion generation in human vascular endothelial cells: role of membrane-bound NADH-/NADPH-oxidases. Cardiovasc Res 1999; 44:215-222.
12. Okamura A, Rakugi H, Ohishi M, Yanagitani Y, Takiuchi S, Moriguchi K, Fennessy PA, Higaki J, Ogihara T. Upregulation of renin-angiotensin system during differentiation of monocytes to macrophages. J Hypertens 1999;17: 537-545.
13. Clapp BR, Hirschfield GM, Storry C, Gallimore JR, Stidwill RP, Singer M, Deanfield JE, MacAllister RJ, Pepys MB, Vallance P, Hingorani AD. Inflammation and endothelial function: direct vascular effects of human C-reactive protein on nitric oxide bioavailability. Circulation 2005;111:1530-1536.
14. Luther JM, Gainer JV, Murphey LJ, Yu C, Vaughan DE, Morrow JD, Brown NJ. Angiotensin II induces interleukin-6 in humans through a mineralocorticoid receptor-dependent mechanism. Hypertension 2006;48:1050-1057.
15. Yamamoto K, Shioi T, Uchiyama K, Miyamoto T, Sasayama S, Matsumori A. Attenuation of virus-induced myocardial injury by inhibition of the angiotensin II type 1 receptor signal and decreased nuclear factor-kappa B activation in knockout mice. J Am Coll Cardiol 2003;42:2000-2006.
16. Wahed MI, Watanabe K, Ma M, Yamaguchi K, Takahashi T, Tachikawa H, Kodama M, Aizawa Y. Effects of eplerenone, a selective aldosterone blocker, on the progression of left ventricular dysfunction and remodeling in rats with dilated cardiomyopathy. Pharmacology 2005;73:81 -88.
17. Thomas CV, Coker ML, Zellner JL, Handy JR, Crumbley AJ III, Spinale FG. Increased matrix metalloproteinase activity and selective upregulation in LV myocardium from patients with end-stage dilated cardiomyopathy. Circulation 1998;97: 1708-1715.
18. Gruber BL, Marchese MJ, Suzuki K, Schwartz LB, Okada Y, Nagase H, Ramamurthy NS. Synovial procollagenase activation by human mast cell tryptase dependence upon matrix metalloproteinase 3 activation. J Clin Invest 1989;84: 1657-1662.
19. Fang KC, Raymond WW, Lazarus SC, Caughey GH. Dog mastocytoma cells secrete a 92-kD gelatinase activated extracellularly by mast cell chymase. J Clin Invest 1996;97:1589-1596.